A five-day treatment course of zanamivir for the flu with a single, self-administered, painless microneedle array patch: Revolutionizing delivery of poorly membrane-permeable therapeutics

Authors:

Abstract
No abstract available
Funding Information
  • Small Business Innovation Research (R44AI129122)
  • Division of Microbiology and Infectious Diseases (272201700041I/HHSN27200003)
  • National Institutes of Health (R43AI129122)

This publication has 35 references indexed in Scilit: